The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.

Background: Circulating tumour cells (CTC) in the blood of cancer patients indicate disease progression. Their presence reflects a relapse or metastasising process since CTC survive only a short time in the circulation.

Materials And Methods: Test systems developed by AdnaGen have been used for the sensitive and specific analysis of CTC.